BIOPHARMACEUTICS INC
8-K, 1997-03-26
PHARMACEUTICAL PREPARATIONS
Previous: BIOPHARMACEUTICS INC, 8-K, 1997-03-26
Next: TRANSCONTINENTAL REALTY INVESTORS INC, 10-K405, 1997-03-26





                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                    Current Report Pursuant to Section 13 or
                  15(d) of the Securities Exchange Act of 1934


           Date of Report (date of earliest event reported): May 1995

                             BIOPHARMACEUTICS, INC.
             (Exact name of Registrant as specified in its Charter)

   DELAWARE                         1-9370                    13-3186327
(State or other                (Commission File Number)    (I.R.S Employer
jurisdiction of                                               I.D. Number)
incorporation)

         990 Station Road
        Bellport, New York                                   11713
(Address of principal executive offices)                   (Zip Code)


          Registrant's telephone number, including area code: (516) 286-5800


                                       N/A
         (Former name or former address, if changed since last report.)

                                       1
<PAGE>


Item 6.  Resignation of Registrant's Directors

         Umbert G. Garistina resigned from the Board of Directors of
Biopharmaceutics, Inc. as of May 19, 1995.






                                  EXHIBIT INDEX

                           Current Report on Form 8-K

                                       of

                             Biopharmaceutics, Inc.

                          Date of Report: June 15, 1995


Exhibits:

 28.5      Letter of Resignation dated May 19, 1995                


                                       2
<PAGE>


                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        BIOPHARMACEUTICS, INC.
                                        (Registrant)

                                         By:  /s/  Edward Fine
                                              --------------------
                                              Edward Fine
                                              President, Chief Executive Officer
                                              (Signature)

Dated:  June 15, 1995

                                       3
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission